Verification evidence is still being completed.
Octapharma
Lachen, Switzerland
- Verified lead
- Wolfgang Marguerre
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chairman and Chief Executive Officer
- 2026 technical specialization
- Plasma Proteins, Recombinant Therapeutics, and Global Biopharma Supply
- Review cycle
- May 2026
- Full address
- Seidenstrasse 2, 8853 Lachen SZ, Switzerland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Octapharma about page confirming Wolfgang Marguerre as Chairman and CEO.
- Editorial note
- Octapharma strengthens the Swiss therapeutics spine with a live official CEO disclosure and a visible industrial plasma-products profile.
Plasma Proteins, Recombinant Therapeutics, and Global Biopharma Supply
GMP plasma-product manufacturing, Global biologics quality systems
Octapharma strengthens the Swiss therapeutics spine with a live official CEO disclosure and a visible industrial plasma-products profile.
Octapharma
Plasma Proteins, Recombinant Therapeutics, and Global Biopharma Supply · Global biologics manufacturing and supply
Octapharma strengthens the Swiss therapeutics spine with a live official CEO disclosure and a visible industrial plasma-products profile.
- Lead
- Wolfgang Marguerre (verified ↗)
- Address
- Seidenstrasse 2, 8853 Lachen SZ, Switzerland (source ↗)
- Compliance
- GMP plasma-product manufacturing
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Global biologics manufacturing and supply
- Capabilities
- Plasma Fractionation · Recombinant Product Supply · Commercial Biopharma Operations
- Founded
- 1983
- Headcount
- 10000+
- Company page (open ↗)
Wolfgang Marguerre
Chairman and Chief Executive Officer
Official Octapharma privacy statement listing Seidenstrasse 2, 8853 Lachen SZ.
Open sourceGlobal biologics manufacturing and supply
Lachen, Switzerland. Plasma Proteins, Recombinant Therapeutics, and Global Biopharma Supply. Review completed on 14 Mar 2026.
Swiss, EMA, FDA, and global biologics oversight
GMP plasma-product manufacturing, Global biologics quality systems
Plasma Proteins, Recombinant Therapeutics, and Global Biopharma Supply
Octapharma strengthens the Swiss therapeutics spine with a live official CEO disclosure and a visible industrial plasma-products profile.
Octapharma strengthens the Swiss therapeutics spine with a live official CEO disclosure and a visible industrial plasma-products profile.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Octapharma located?
- Octapharma operates from Seidenstrasse 2, 8853 Lachen SZ, Switzerland, Lachen, Switzerland.
- Who runs Octapharma?
- Octapharma is led by Wolfgang Marguerre, Chairman and Chief Executive Officer. Verified 14 Mar 2026.
- What certifications does Octapharma hold?
- Octapharma is documented under GMP plasma-product manufacturing.
- What does Octapharma do?
- Octapharma strengthens the Swiss therapeutics spine with a live official CEO disclosure and a visible industrial plasma-products profile. Core capabilities: Plasma Fractionation, Recombinant Product Supply, Commercial Biopharma Operations.
Related technical briefs
Briefs that name Lachen as a covered market or city.
